National Account Manager
Akebia Therapeutics
National Account Manager
Akebia Therapeutics
Develops CKD anemia therapies
Job Summary:
The National Account Manager (NAM) is responsible for developing and executing strategic account plans to optimize access, sales and outcomes for Akebia’s approved product by building strategic partnerships between Akebia and with Large and Medium size Dialysis Organizations (LDOs/MDOs) through strong engagement with populations health decision-makers and other key LDO/MDO leadership including Regional Vice Presidents (RVP), Area/Directors and Regional Quality Managers (RQM) and other key LDO/MDO executives. In addition, this role would be responsible for building strategic partnerships between Akebia and Nephrology Large Group Practices (LGP) and Integrated Delivery Networks (IDNs) hat treat patients on Dialyisis. The NAMs strategic partnerships will facilitate alignment of mutual business goals and identify new opportunities for collaboration and integration with Nephrology National Accounts / Large Group Practices and AKEBIA. NAMs are responsible for driving dialysis pull through of Akebia National Account strategies and ensuring alignment and execution of LDO/MDO strategies pertaining to Vafseo adoption as well as related LGP pull through.
The NAM is the critical link connecting the Akebia’s National Account Strategies to its most strategic customers ensuring understanding alignment on clinical, economic and operational value propositions. The NAM will work in close collaboration with both National Account Directors and Medical Affairs.
The primary region for this role is Northern California (San Francisco, Fresno, Oakland/Fremont, Sacramento)
Essential Functions & Duties
Skills & Experience
Basic Qualifications
Preferred Qualifications
Base Compensation for this role will depend on a number of factors including a candidate’s qualifications, skills, competencies, and experience, and may fall outside of the range shown. Base pay is only one component of the company’s total rewards package, all regular employees are also eligible for the corporate bonus program or the incentive compensation program (if applicable), as well as equity. Additional benefits include health care, vision, dental, retirement, PTO, etc.
Targeted Base Salary 178664 - 220703 USD
Develops CKD anemia therapies
Akebia Therapeutics focuses on developing and commercializing therapies for chronic kidney disease (CKD), especially anemia related to CKD. Its lead product candidate, vadadustat, is in global Phase 3 trials. The company conducts research, clinical development, and strategic partnerships to bring therapies to market, generating revenue from product sales, licensing, and collaborations. Akebia's goal is to improve the quality of life for CKD patients by providing effective treatments through a science-driven biopharmaceutical approach based in Cambridge, MA.
Explore more opportunities at Akebia Therapeutics